Table 1 Correlation between the PCNP expression in cytoplasmic fraction and clinicopathological characteristics of LIHC.
Factor | N | Total N | Correlation coefficient | Significance (2-tailed) |
|---|---|---|---|---|
Gender | ||||
Male | 74 | 87 | − 0.066 | 0.542 |
Female | 13 | |||
Age (y) | ||||
≤ 60 | 72 | 87 | − 0.016 | 0.884 |
>60 | 15 | |||
Tumor size (cm) | ||||
≤ 3 | 38 | 87 | − 0.002 | 0.984 |
>3 | 49 | |||
Tumor number | ||||
1 | 74 | 87 | − 0.055 | 0.613 |
>1 | 13 | |||
Pahtological grading | ||||
I | 1 | 87 | − 0.029 | 0.788 |
I–II/II | 54 | |||
II–III/III | 32 | |||
T staging | ||||
T1 stage | 58 | 87 | 0.245 | 0.022 |
T2 stage | 29 | |||
Clinical staging | ||||
I | 23 | 87 | 0.245 | 0.022 |
II–III/III | 64 | |||
Recurrence | ||||
No | 37 | 80 | 0.228 | 0.042 |
Yes | 43 | |||
